Home

Kadidlo Asimilace Nešikovný overall survival nosič informace Zúčtovatelný

Overall Survival. Kaplan-Meier estimates of overall survival in... |  Download Scientific Diagram
Overall Survival. Kaplan-Meier estimates of overall survival in... | Download Scientific Diagram

Predictors of progression free survival, overall survival and early  cessation of chemotherapy in women with potentially platinum sensitive  (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3)  chemotherapy – The GCIG
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG

Time Trends of Overall Survival and Survival after Recurrence in Completely  Resected Stage I Non-small Cell Lung Cancer - Journal of Thoracic Oncology
Time Trends of Overall Survival and Survival after Recurrence in Completely Resected Stage I Non-small Cell Lung Cancer - Journal of Thoracic Oncology

Validation of an assessment tool: Estimation of Postoperative Overall  Survival for Gastric Cancer - European Journal of Surgical Oncology
Validation of an assessment tool: Estimation of Postoperative Overall Survival for Gastric Cancer - European Journal of Surgical Oncology

Circulating inflammation signature predicts overall survival and  relapse-free survival in metastatic colorectal cancer.,British Journal of  Cancer - X-MOL
Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer.,British Journal of Cancer - X-MOL

ADMIRAL Trial: XOSPATA® (gilteritinib) Overall Survival
ADMIRAL Trial: XOSPATA® (gilteritinib) Overall Survival

図14 Overall Survival
図14 Overall Survival

View Image
View Image

Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in  Stage III NSCLC—Update from PACIFIC - Journal of Thoracic Oncology
Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC - Journal of Thoracic Oncology

図11 Overall Survival (Updated)
図11 Overall Survival (Updated)

A prognostic model for overall survival of patients with early-stage  non-small cell lung cancer: a multicentre, retrospective study - The Lancet  Digital Health
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health

The development and external validation of an overall survival nomogram in  medically inoperable centrally located early-stage non-small cell lung  carcinoma - Radiotherapy and Oncology
The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma - Radiotherapy and Oncology

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC  | NEJM
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC | NEJM

Long-term follow-up of overall survival for cabozantinib versus everolimus  in advanced renal cell carcinoma | British Journal of Cancer
Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma | British Journal of Cancer

Significant predictors of overall survival in patients with hepatocellular  carcinoma after surgical resection | PLOS ONE
Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection | PLOS ONE

Overall survival for oncology drugs approved for genomic indications -  European Journal of Cancer
Overall survival for oncology drugs approved for genomic indications - European Journal of Cancer

Identification and validation of an epithelial mesenchymal  transition-related gene pairs signature for prediction of overall survival  in patients with skin cutaneous melanoma [PeerJ]
Identification and validation of an epithelial mesenchymal transition-related gene pairs signature for prediction of overall survival in patients with skin cutaneous melanoma [PeerJ]

Event-free survival > Overall survival? - data analysis - Datamethods  Discussion Forum
Event-free survival > Overall survival? - data analysis - Datamethods Discussion Forum

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC  | NEJM
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC | NEJM

JCI Insight - Mutational analysis of head and neck squamous cell carcinoma  stratified by smoking status
JCI Insight - Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status

The prognostic impact of RAS on overall survival following liver resection  in early versus late-onset colorectal cancer patients | British Journal of  Cancer
The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients | British Journal of Cancer

Overall survival and cancer-specific survival in patients with surgically  resected pancreatic head adenocarcinoma: A competing risk nomogram analysis
Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis

Correlation of Prostate-specific Antigen Kinetics with Overall Survival and  Radiological Progression-free Survival in Metastatic Castration-sensitive  Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or  Placebos Added to Androgen ...
Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen ...

Overall survival and cancer-specific survival in patients with surgically  resected pancreatic head adenocarcinoma: A competing risk nomogram analysis
Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis

Overall survival. The Kaplan-Meier graph shows overall survival of the... |  Download Scientific Diagram
Overall survival. The Kaplan-Meier graph shows overall survival of the... | Download Scientific Diagram

Overall survival of stage IV non-small cell lung cancer patients treated  with Viscum album L. in addition to chemotherapy, a real-world  observational multicenter analysis | PLOS ONE
Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis | PLOS ONE

Fig. 3, [Kaplan-Meier curves showing overall survival...]. - Brain and  Human Body Modeling 2020 - NCBI Bookshelf
Fig. 3, [Kaplan-Meier curves showing overall survival...]. - Brain and Human Body Modeling 2020 - NCBI Bookshelf

Final overall survival results of WJTOG3405, a randomized phase III trial  comparing gefitinib versus cisplatin with docetaxel as the first-line  treatment for patients with stage IIIB/IV or postoperative recurrent EGFR  mutation-positive non-small-cell
Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small-cell